AnaptysBio Inc buy Guggenheim
Start price
10.03.25
/
50%
€15.30
Target price
10.03.26
-
Performance (%)
246.41%
End price
11.03.26
€53.00
Summary
This prediction ended on 11.03.26 with a price of €53.00. With a performance of 246.41% the BUY prediction by Guggenheim was a big success. Guggenheim has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 4.692% | 4.692% | 191.353% |
| iShares Core DAX® | 0,18 % | 5,07 % | 8,98 % |
| iShares Nasdaq 100 | -0,77 % | -2,08 % | 26,44 % |
| iShares Nikkei 225® | 0,73 % | -3,35 % | 47,89 % |
| iShares S&P 500 | -0,17 % | 0,90 % | 22,97 % |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten